Cutaneous manifestations of cancer

Current Opinion in Oncology

Volumn 11, Issue 2, 1999, Pages 139-144

  Sabir, Smeena ^a   James, William D ^a   Schuchter, Lynn M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; AMYLOIDOSIS; CANCER THERAPY; CARCINOID SYNDROME; ERYTHEMA; GENETIC DISORDER; HUMAN; HYPERTRICHOSIS; KERATOSIS PALMOPLANTARIS; LEUKEMIA CELL; MELANOMA; METASTASIS; PAGET SKIN DISEASE; PARANEOPLASTIC SYNDROME; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN CANCER; SKIN DEFECT; SKIN DISEASE; XANTHOMA;

HUMANS; NEOPLASM METASTASIS; PAGET'S DISEASE, MAMMARY; PARANEOPLASTIC SYNDROMES; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0033022754     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199903000-00011     Document Type: Review

References (72)

1. Lookingbill DP, Spangler N, Sexton FM: Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7616 cancer patients. J Am Acad Dermatol 1990, 22:19-26.
2. Arnold HL, Odom RB, James WD: Andrew's Diseases of the Skin: Clinical Dermatology, edn 8. Philadelphia, PA: W.B. Saunders; 1990:607.
3. Marien KJC, Smeenk G: Plane xanthomata associated with multiple myeloma and hyperlipoproteinaemia. Br J Dermatol 1975, 93:407-415.
4. Cohen PR, Grossman ME, Almeida L, et al.: Tripe palms and cancer. J Clin Oncol 1989, 7:669-678.
5. Schwartz R: Acanthosis nigricans. J Am Acad Dermatol 1994, 31:1-19.
6. Matsuoka LY, Wortsman J, Goldman J: Acanthosis nigricans. Clin Dermatol 1993, 11:21-25.
7. Katz RA: Treatment of acanthosis nigricans with oral isotretinoin. Arch Dermatol 1980, 116:110-111.
8. Berger BJ, Gross PR: Another use for tretinoin-pseudoacanthosis nigricans. Arch Dermatol 1973, 108:133-134.
9. Caplin ME, Buscombe JR, Hilson AJ, et al.: Carcinoid tumour. Lancet 1998, 352:799-805.
10. Maton PN: The carcinoid syndrome. JAMA 1988, 260:1602-1605.
11. Vinik A, Gonin J, England B, Jackson T, McLeod MK, Cho K: Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog. J Clin Endocrinol Metab 1990, 70:1702-1709.
12. Norton JA: Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 1994, 55(Suppl 3):98-103.
13. Altman AR, Tschen JA, Rice L: Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue. Arch Dermatol 1989, 125:394-396.
14. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG: Treatment of the malignant carcinoid syndrome. N Engl J Med 1985, 315:663-666.
15. Callen JP: Myositis and malignancy. Curr Opin Rheumatol 1994, 6:590-594.
16. Sigurgeirsson B, Lindelof B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992, 326:363-367. This comprehensive review presents the association of cancer in patients with dermatomyositis or polymyositis.
17. Cox NH, Lawrence CM, Langtry JAA, Ive FA: Dermatomyositis. Arch Dermatol 1990, 126:61-65.
18. Till SH, Jones AC: Dermatomyositis: how far to go. Ann Rheum Dis 1998, 57:198-200.
19. Zantos D, Zhang Y, Felson D: The overall and temporal relationship association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994, 21:1855-1859.
20. Jacobsen FK, Abildtrup N, Laursen S, Brandrup F, Jensen NK: Acrokeratosis paraneoplastica (Bazex syndrome). Arch Dermatol 1984, 120:502-504.
21. Richard M, Giroux J: Acrokeratosis paraneoplastica (Bazex' syndrome). J Am Acad Dermatol 1987, 16:178-183.
22. Wishart JM: Bazex paraneoplastic acrokeratosis: a case report and response to Tigason. Br J Dermatol 1986, 115:595-599
23. Boyd AS, Neldner KH, Menter A: Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol 1992, 26:757-762.
24. Kurzrock R, Cohen PR: Erythema gyratum repens. JAMA 1995, 273:594.
25. Tyring SK: Reactive erythemas: erythema annulare centrifugum and erythema gyratum repens. Clin Dermatol 1993, 11:135-139.
26. Appell ML, Ward WQ, Tyring SK: Erythema gyratum repens. Cancer 1988, 62:548-550.
27. Schwartz RA: Sign of Leser-Trelat. J Am Acad Dermatol 1996, 35:88.
28. Ellis DL, Yates RA: Sign of Leser-Trelat. Clin Dermatol 1993, 11:141-148.
29. Hovenden AL: Hypertrichosis lanuginosa acquisita associated with malignancy. Clin Dermatol 1993, 11:99-106.
30. Fretzin DF: Malignant down. Arch Dermatol 1967, 95:294-297.
31. Solis JA, Betancor P, Campos R, Enriquez-Salamanca RE, Rojo P, Marin I, et al.: Association of porphyria cutanea tarda and primary liver cancer. J Dermatol 1982, 9:131-137.
32. Kauppinen R, Mustajoki P: Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 1988, 57:117-120.
33. Fett DL, Gibson LE, Su WPD: Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995, 70:234-240.
34. Su WPD, Fett DL, Gibson LE, Pittelkow MR: Sweet syndrome: acute febrile neutrophilic dermatosis. Semin Dermatol 1995, 14:173-178. This article presents a comprehensive review of this uncommon condition.
35. Kasper CS: Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review. Cutis 1992, 49:120-122.
36. Wynick D, Hammond PJ, Bloom SR: The glucagonoma syndrome. Clin Dermatol 1993, 11:93-97.
37. Hashizume T, Kiryu H, Noda K, et al.: Glucagonoma syndrome. J Am Acad Dermatol 1988, 19:377-383.
38. Tschen JA: Amyloidosis and neoplasia. Clin Dermatol 1993, 11:33-36.
39. Kyle RA, Gertz MA: Systemic amyloidosis. Crit Rev Oncol Hematol 1990, 10:49-87.
40. Falk RH, Comenzo RL, Skinner M: The systemic amyloidoses. N Engl J Med 1997, 337:898-909. This is an excellent review on the topic of amyloidosis.
41. Ratnavel RC, Griffiths WAD: The inherited palmoplantar keratodermas. Br J Dermatol 1997, 137:485-490.
42. Khanna SK, Agnone FA, Leibowitz AI: Nonfamilial diffuse palmoplantar keretoderma associated with bronchial carcinoma. J Am Acad Dermatol 1993, 28:295-297.
43. Itin PH, Lautenschlager S: Palmoplantar keratoderma and associated syndromes. Semin Dermatol 1995, 14:152-161.
44. Torchard D, Blanchet-Bardon, Serova O, et al.: Epidermolytic palmoplantar keratoderma congregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet 1994, 6:106-110.
45. Bennion SD, Patterson JW: Keratosis punctata palmaris palmads et plantaris and adenocarcinoma of the colon. J Am Acad Dermatol 1984, 10:587-591.
46. Stevens HP, Kelsell DP, Leigh IM, et al.: Punctate palmoplantar keratoderma and malignancy in a four-generation family. Br J Dermatol 1996, 134:720-726.
47. Kelsell DP, Stevens HP, Ratnavel R, Bryant SP, Bishop DT, Leigh IM, Spurr NK: Genetic linkage studies in non-epidermolytic palmoplantar keratoderma: evidence for heterogeneity. Hum Mol Genet 1995, 4:1021-1025.
48. Spigelman AD, Murday V, Phillips RKS: Cancer and the Peutz-Jeghers syndrome. Gut 1989, 30:1588-1590.
49. Giardiello FM, Welsh SB, Hamilton SR: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987, 316:1511-1514.
50. Jenne DE, Reimann H, Nezu J, et al.: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998, 18:38-43.
51. Barax CN, Lebwohl M, Phelps RG: Multiple hamartoma syndrome. J Am Acad Dermatol 1987, 17:342-346.
52. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M: Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol 1989, 29:47-53.
53. Cnudde F, Boulard F, Muller P, et al.: Cowden's disease: treatment with acitretin. Ann Dermatol Venereol 1996, 123:739-741.
54. Perniciaro C: Gardner's syndrome. Dermatol Clin 1995, 13:51-56.
55. Leppert M, Dobbs M, Scambler P, et al.: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987, 238:1411-1413.
56. Powell SM, Peterson GM, Krush AJ, et al.: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993, 329:1982-1987. This article is an outstanding review of the current reccomendations for evaluating patients with familial adenomatous polyposis and those at risk for familial adenomatous polyposis.
57. Mautner VF, Lindenau M, Baser ME, et al.: Skin abnormalities in neurofibromatosis 2. Arch Dermatol 1997, 133:1539-1543.
58. Huson SM, Compston DAS, Harper PS: A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counseling. J Med Genet 1989, 26:712-721.
59. Rouleau GA, Wertelecki W, Haines JL, et al.: Flanking markers bracket the neurofibromatosis Type 2 (NF2) gene on chromosome 22. Am J Hum Genet 1990, 46:323-328.
60. Cohen PR, Kohn SR, Davis D, et al.: Muir-Torre syndrome. Dermatol Clin 1995, 13:79-89.
61. Schwartz RA, Torre DP: the Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995, 33:90-104.
62. Gorlin RJ: Nevoid Basal-cell carcinoma syndrome. Dermatol Clin 1995, 13:113-125. This is a comprehensive review of the basal cell nevus syndrome which includes important guidelines concerning malignancy.
63. Shanley S, Ratcliffe J, Hockey A, et al: Nevoid basal cell carcinoma syndrome. Review of 118 affected individuals. Am J Med Genet 1994, 50:282-290. This is the largest series describing patients with basal cell nevus syndrome.
64. Kimonis VE, Goldstein AM, Pastakia B, et al.: Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997, 69:299-308.
65. Gatti RA, Boder E, Vinters HV, et al.: Ataxia telangiectasis. Immunol Rev 1990, 2:67.
66. Ellis NA, Groden J, Ye T-Z: The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995, 83:655-666.
67. Gordon-Smith EC, Rutherford TR: Fanconi's anaemia-constitutional, familial aplastic anaemia. Ballieres Clin Haematol 1989, 2:139-152.
68. Kwan Sp, Lehner T, Hagemann T, et al.: Localization of the gene for the Wiskott Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-X11.3. Genomics 1991, 10:29-33.
69. Ratnam KV, Khor CJL, Su WPD: Leukemia cutis. Dermatol Clin 1994, 12:419-431.
70. Lookingbill DP, Spangler N, Sexton FM: Skin involvement as the presenting sign of intemal carcinoma: a retrospective study of 7616 cancer patients. J Am Acad Dermatol 1990, 22:19-26.
71. Kollmorgen DR, Varanasi JS, Edge SB, et al.: Paget's disease of the breast: a 33-year experience. J Am Coll Surg 1998, 187:171-177.
72. Heymann WR: Extramammary Paget's disease. Clin Dermatol 1993, 11:83-87.